D Daiichi Sankyo
Updates & Highlights
simplywall.st · about 1 month ago
Earnings Troubles May Signal Larger Issues for Daiichi Sankyo Company (TSE:4568) Shareholders
BioPharma APAC · about 1 month ago
Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China
Pharmaceutical Executive · about 1 month ago
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
Recent Openings
View all 1 jobs arrow_forwardData Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
All Jobs
Data Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Daiichi Sankyo?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentEarnings Troubles May Signal Larger Issues for Daiichi Sankyo Company (TSE:4568) Shareholders
Earnings Troubles May Signal Larger Issues for Daiichi Sankyo Company (TSE:4568) Shareholders
simplywall.st · about 1 month ago
Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China
Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China
BioPharma APAC · about 1 month ago
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
Pharmaceutical Executive · about 1 month ago
Innovent and Daiichi Sankyo sign deal for Vanflyta in China
Innovent and Daiichi Sankyo sign deal for Vanflyta in China
Pharmaceutical Technology · about 1 month ago
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
marketscreener.com · about 1 month ago
Delhi HC set to rule on Daiichi Sankyo arbitration case
Delhi HC set to rule on Daiichi Sankyo arbitration case
The Economic Times · about 1 month ago
Toyota Stock, SoftBank And Daiichi Sankyo For Dividend Income Watchlists
Toyota Stock, SoftBank And Daiichi Sankyo For Dividend Income Watchlists
webull.com · about 1 month ago
Daiichi Sankyo (TSE:4568) Stock Revenue Surges While Margins Stay Under Pressure
Daiichi Sankyo (TSE:4568) Stock Revenue Surges While Margins Stay Under Pressure
webull.com · about 1 month ago
Watch Daiichi Sankyo: Weaker Yen Boosts Topline Growth
Watch Daiichi Sankyo: Weaker Yen Boosts Topline Growth
Bloomberg.com · about 1 month ago
Daiichi Sankyo (TSE:4568) Stock Revenue Surges While Margins Stay Under Pressure
Daiichi Sankyo (TSE:4568) Stock Revenue Surges While Margins Stay Under Pressure
simplywall.st · about 1 month ago
Q1 2027 Daiichi Sankyo Co Ltd Earnings Presentation (Japanese) Transcript
Q1 2027 Daiichi Sankyo Co Ltd Earnings Presentation (Japanese) Transcript
GuruFocus · about 1 month ago
Daiichi Sankyo Company: Q1 FY 2026 revenue up 21% YoY, forecast raised on strong oncology sales and yen weakness
Daiichi Sankyo Company: Q1 FY 2026 revenue up 21% YoY, forecast raised on strong oncology sales and yen weakness
TradingView · about 1 month ago
Daiichi Sankyo Company: Q1 FY 2026 revenue jumped 21%, but operating profit fell due to restructuring costs
Daiichi Sankyo Company: Q1 FY 2026 revenue jumped 21%, but operating profit fell due to restructuring costs
TradingView · about 1 month ago
Earnings call transcript: Daiichi Sankyo Q1 2026 revenue beats, EPS misses as stock sinks
Earnings call transcript: Daiichi Sankyo Q1 2026 revenue beats, EPS misses as stock sinks
Investing.com · about 1 month ago
Daiichi Sankyo wins EU approval for Datroway in TNBC
Daiichi Sankyo wins EU approval for Datroway in TNBC
International Business Times · about 1 month ago
Daiichi Sankyo Company, Limited Revises Earnings Guidance for the Full Year 2026
Daiichi Sankyo Company, Limited Revises Earnings Guidance for the Full Year 2026
marketscreener.com · about 1 month ago
Transcript : Daiichi Sankyo Company, Limited, Q1 2027 Earnings Call, Jul 31, 2026
Transcript : Daiichi Sankyo Company, Limited, Q1 2027 Earnings Call, Jul 31, 2026
marketscreener.com · about 1 month ago
Press Release: Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
Press Release: Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
Moomoo · about 1 month ago
Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
Yahoo Finance · about 1 month ago
Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
Fierce Pharma · about 1 month ago